Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-25T18:28:10.814Z Has data issue: false hasContentIssue false
  • English
  • Français

Factors Associated with the Prevalence of Antibiotic Use for the Treatment of Hospital-Acquired Infections at 393 French Hospitals: A Regional Variation Analysis

Published online by Cambridge University Press:  02 January 2015

B. Amadeo ,
C. Dumartin ,
A. G. Venier ,
A. Fourrier-Réglat ,
B. Coignard  and
A. M. Rogues
B. Amadeo*
Affiliation:
Institut National de la Santé et de la Recherche Médicale, Unité 657, Université de Bordeaux 2, Bordeaux, France
C. Dumartin
Affiliation:
Institut National de la Santé et de la Recherche Médicale, Unité 657, Université de Bordeaux 2, Bordeaux, France Centre de Coordination de la Lutte contre les Infections Nosocomiales du Sud-Ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
A. G. Venier
Affiliation:
Institut National de la Santé et de la Recherche Médicale, Unité 657, Université de Bordeaux 2, Bordeaux, France Centre de Coordination de la Lutte contre les Infections Nosocomiales du Sud-Ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Service d'Hygiène Hospitalière, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
A. Fourrier-Réglat
Affiliation:
Institut National de la Santé et de la Recherche Médicale, Unité 657, Université de Bordeaux 2, Bordeaux, France Service de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
B. Coignard
Affiliation:
Institut de veille sanitaire, Paris, France
A. M. Rogues
Affiliation:
Institut National de la Santé et de la Recherche Médicale, Unité 657, Université de Bordeaux 2, Bordeaux, France Centre de Coordination de la Lutte contre les Infections Nosocomiales du Sud-Ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Service d'Hygiène Hospitalière, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
*
Service d'Hygiène Hospitalière, INSERM, Unité 657, Båt PQR Entrée 1, 1 Ère Étage, CHU Bordeaux, 33076 Bordeaux, France ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

The present study investigated regional variations in antibiotic use for the treatment of hospital-acquired infections (HAIs) in France by means of a multilevel analysis, to identify targets for quality improvement.

Methods.

Data were obtained from the 2001 and 2006 French national point-prevalence surveys of HAIs and antibiotic use. The present study was conducted using data from 393 nonteaching public hospitals. Data included patient characteristics calculated at the hospital level (mean age and proportion of patients with the following: HAI, presence of a vascular catheter, presence of a urinary catheter, surgical procedure, and immunodeficiency) and hospital characteristics (size and presence of an intensive care unit). The regional effect was measured using a random intercept on a regional variable.

Results.

Overall, the prevalence of antibiotic use was 5.35% for both study years. The most commonly used antibiotics for HAIs were fluoroquinolones (2001, 1.33%; 2006, 1.35%) and combinations of penicillins with a β-lactamase inhibitor (2001, 0.92%; 2006, 1.02%). Mapping of antibiotic use showed wide variation between regions. The regional effect explained 3% of antibiotic variation in the unadjusted analysis. In the multivariable analysis, hospital size, high prevalence of patients with immunodeficiency, and infection characteristics explained 45% of the variability in antibiotic use. The regional effect was not retained in the final model.

Conclusion.

The pattern of antibiotic use for HAIs differed over time, and regional variations were mostly explained by patient characteristics; there was no regional effect. Models that take data hierarchy into account are essential to better approach antibiotic use and develop relevant strategies for improvement.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 2 , February 2011 , pp. 155 - 162
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Rogues, AM, Placet-Thomazeau, B, Parneix, P, et al. Use of antibiotics in hospitals in south-western France. JHosp Infect 2004;58:187–192.Google ScholarPubMed
2. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin). Surveillance de la consommation des antibiotiques: Réseau ATB-Raisin–Résultats 2008. http://www.invs.sante.fr/publications/2010/atb_raisin/rapport_atb_raisin.pdf. Accessed December 24, 2010.Google Scholar
3. Maugat, D, Thiolet, JM, L'Hériteau, F, et al. Prévalence des traitements antibiotiques dans les établissements de santé, France. BEH 2007;51-52:432–437.Google Scholar
4. European Commission. Second report from the commission to the council on the basis of member states' reports on the implementation of the council recommendation (2002/77/EC) on the prudent use of antimicrobial agents in human medicine. Brussels: European Commission, 2010. http://www.ec.europa.eu/health/anti microbial_resistance/docs/amr_report2_en.pdf. Accessed July 5, 2010.Google Scholar
5. Desenclos, JC. RAISIN–a national programme for early warning, investigation and surveillance of healthcare-associated infection in France. Euro Surveill 2009;14:pii= 19408. http://www.euro survefflance.org/images/dynamic/EE/V14N46/artl9408.pdf. Accessed December 24, 2010.Google Scholar
6. Pan, Z, Hu, D. Multilevel analysis of individual and community predictors of smoking prevalence and frequency in China:1991-2004. J Public Health Policy 2008;29:72–85.CrossRefGoogle Scholar
7. Singer, JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models and individual growth models. J Educ Behav Stat 1998;24:323–355.CrossRefGoogle Scholar
8. Twisk, JWR. Applied multilevel analysis. New York, NY: Cambridge University Press, 2006.CrossRefGoogle Scholar
9. Muller, A, Mauny, F, Talon, D, et al. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006;58:878–881.CrossRefGoogle ScholarPubMed
10. Grammatico-Guillon, L, Thiolet, J-M, Bernillon, P, et al. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals. Infect Control Hosp Epidemiol 2009;30:861–869.CrossRefGoogle Scholar
11. Benoit, SR, Nsa, W, Richards, CL, et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008;56:2039–2044.CrossRefGoogle ScholarPubMed
12. Amadeo, B, Dumartin, C, Robinson, P, et al. Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France. Clin Microbiol Infect 2010;16:735–741.CrossRefGoogle Scholar
13. Lee, MK, Chiù, CS, Chow, VC, et al. Prevalence of hospital infection and antibiotic use at a university medical center in Hong Kong. J Hosp Infect 2007;65:341–347.CrossRefGoogle Scholar
14. Ufer, M, Radosevic, N, Vogt, A, et al. Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf 2005;14:735–739.CrossRefGoogle ScholarPubMed
15. Hajdu, A, Samodova, OV, Carlsson, TR, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect 2007;66:378–384.CrossRefGoogle Scholar
16. Usluer, G, Ozgunes, I, Leblebicioglu, H. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob 2005;4:16.CrossRefGoogle ScholarPubMed
17. Gravel, D, Taylor, G, Ofner, M, et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007;66:243–248.CrossRefGoogle ScholarPubMed
18. Pellizzer, G, Mantoan, P, Timillero, L, et al. Prevalence and risk factors for nosocomial infections in hospitals of the Veneto region, north-eastern Italy. Infection 2008;36:112–119.CrossRefGoogle ScholarPubMed
19. Seaton, RA, Nathwani, D, Burton, P, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents 2007;29:693–699.CrossRefGoogle ScholarPubMed
20. Neuhauser, MM, Weinstein, RA, Rydman, R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003;289:885–888.CrossRefGoogle ScholarPubMed
21. Casey, AL, Elliott, TS. Progress in the prevention of surgical site infection. Curr Opin Infect Dis 2009;22:370–375.CrossRefGoogle ScholarPubMed
22. Labeau, SO, Vandijck, DM, Relio, J, et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med 2009;37:320–323.CrossRefGoogle ScholarPubMed
23. Benko, R, Matuz, M, Doro, P, et al. Hungarian hospital antibiotic consumption at the regional level, 1996-2005. Infection 2009;37:133–137.CrossRefGoogle ScholarPubMed
24. Blix, HS, Hartug, S. Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005;14:647–649.CrossRefGoogle ScholarPubMed
25. de With, K, Steib-Bauert, M, Straach, P, et al. Is there significant regional variation in hospital antibiotic consumption in Germany? Infection 2006;34:274–277.CrossRefGoogle ScholarPubMed
26. Carlet, J, Astagneau, P, Brun-Buisson, C, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30:737–745.CrossRefGoogle ScholarPubMed
27. Ansari, F, Ernteil, M, Goossens, H, et al. The European Surveillance of Antimicrobial Consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009;49:1496–1504.CrossRefGoogle ScholarPubMed